---
title: "Ocugen Inc. Stock Falls Thursday, Underperforms Market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285624098.md"
description: "Shares of Ocugen Inc. (OCGN) fell 1.03% to $1.44 on Thursday, marking the third consecutive day of losses amid a broader market decline, with the S&P 500 down 0.38% and the Dow Jones down 0.63%. The stock is currently 47.16% below its 52-week high of $2.73 reached on March 17. Trading volume was 13.6 million, surpassing the 50-day average of 9.6 million."
datetime: "2026-05-07T21:30:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285624098.md)
  - [en](https://longbridge.com/en/news/285624098.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285624098.md)
---

# Ocugen Inc. Stock Falls Thursday, Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Ocugen Inc. (OCGN) slipped 1.03% to $1.44 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.38% to 7,337.11 and Dow Jones Industrial Average falling 0.63% to 49,596.97.

This was the stock's third consecutive day of losses.

Ocugen Inc. closed 47.16% below its 52-week high of $2.73, which the company reached on March 17th.

Trading volume (13.6 M) eclipsed its 50-day average volume of 9.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled May 7, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

05-07-26 1730ET

### Related Stocks

- [OCGN.US](https://longbridge.com/en/quote/OCGN.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [513500.CN](https://longbridge.com/en/quote/513500.CN.md)
- [159612.CN](https://longbridge.com/en/quote/159612.CN.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [SPY.US](https://longbridge.com/en/quote/SPY.US.md)
- [IVV.US](https://longbridge.com/en/quote/IVV.US.md)
- [VOO.US](https://longbridge.com/en/quote/VOO.US.md)
- [1546.JP](https://longbridge.com/en/quote/1546.JP.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [DIA.US](https://longbridge.com/en/quote/DIA.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)
- [NWSA.US](https://longbridge.com/en/quote/NWSA.US.md)
- [NWS.US](https://longbridge.com/en/quote/NWS.US.md)
- [NWS.AU](https://longbridge.com/en/quote/NWS.AU.md)
- [NWSLV.AU](https://longbridge.com/en/quote/NWSLV.AU.md)

## Related News & Research

- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)
- [Roivant posts unexpected Q4 profit due to Moderna lawsuit settlement gain](https://longbridge.com/en/news/287053604.md)
- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)
- [Candel Therapeutics Reports Positive Phase 3 Prostate Cancer Trial Data](https://longbridge.com/en/news/286652611.md)
- [Rani Therapeutics Q1 contract revenue rises on Chugai collaboration; announces CFO transition](https://longbridge.com/en/news/286608288.md)